substance p has been researched along with methoxyhydroxyphenylglycol in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (33.33) | 18.7374 |
| 1990's | 3 (50.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bisette, G; Gislason, T; Hedner, J; Nemeroff, CB; Terenius, L | 1 |
| Bouckoms, AJ; Carr, D; Keith, D; Poletti, CH; Sweet, WH | 1 |
| Almay, BG; Johansson, F; Sakurada, T; Terenius, L; von Knorring, L | 1 |
| Bertilsson, L; Brodin, E; Mårtensson, B; Nyberg, S; Toresson, G | 1 |
| Arcaya, JL; Cano, G; Cuesta, MC; Maixner, W; Sanchez, L; Suarez-Roca, H | 1 |
| Freund, TF; Hájos, N; Pálhalmi, J; Paulsen, O | 1 |
1 review(s) available for substance p and methoxyhydroxyphenylglycol
| Article | Year |
|---|---|
Trigeminal facial pain: a model of peptides and monoamines in intracerebral cerebrospinal fluid.
Topics: Biogenic Monoamines; Electrochemistry; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Methoxyhydroxyphenylglycol; Models, Chemical; Peptides; Substance P; Trigeminal Neuralgia | 1991 |
5 other study(ies) available for substance p and methoxyhydroxyphenylglycol
| Article | Year |
|---|---|
Substance P, thyrotropin-releasing hormone, and monoamine metabolites in cerebrospinal fluid in sleep apnea patients.
Topics: Adult; Biogenic Monoamines; Chromatography, High Pressure Liquid; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Middle Aged; Sleep Apnea Syndromes; Substance P; Thyrotropin-Releasing Hormone | 1992 |
Long-term high frequency transcutaneous electrical nerve stimulation (hi-TNS) in chronic pain. Clinical response and effects on CSF-endorphins, monoamine metabolites, substance P-like immunoreactivity (SPLI) and pain measures.
Topics: Adult; Aged; Chronic Disease; Electric Stimulation Therapy; Endorphins; Female; Follow-Up Studies; Glycols; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Middle Aged; Pain; Pain Management; Phenylacetates; Radioimmunoassay; Substance P; Transcutaneous Electric Nerve Stimulation | 1985 |
Fluoxetine treatment of depression. Clinical effects, drug concentrations and monoamine metabolites and N-terminally extended substance P in cerebrospinal fluid.
Topics: Adult; Aged; Depressive Disorder; Female; Fluoxetine; Glycols; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Middle Aged; Peptide Fragments; Substance P | 1989 |
Opposite modulation of capsaicin-evoked substance P release by glutamate receptors.
Topics: Afferent Pathways; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Benzoates; Capsaicin; Dizocilpine Maleate; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Glycine; Kainic Acid; Male; Methoxyhydroxyphenylglycol; Nerve Fibers; Nociceptors; Propionates; Rats; Rats, Sprague-Dawley; Receptors, Glutamate; Receptors, Metabotropic Glutamate; Receptors, N-Methyl-D-Aspartate; Substance P; Trigeminal Nuclei | 1999 |
Distinct properties of carbachol- and DHPG-induced network oscillations in hippocampal slices.
Topics: Action Potentials; Amino Acids; Animals; Animals, Newborn; Benzodiazepines; Bicuculline; Carbachol; Cholinergic Agonists; Diamines; Dose-Response Relationship, Drug; Drug Interactions; Excitatory Amino Acid Antagonists; GABA Agonists; GABA Antagonists; Hippocampus; In Vitro Techniques; Male; Methoxyhydroxyphenylglycol; Muscarinic Antagonists; Pirenzepine; Pyridines; Rats; Receptors, Metabotropic Glutamate; Spectrum Analysis; Substance P; Xanthenes; Zolpidem | 2004 |